UK Politicians Want NICE To Use Conditional Reimbursement
A UK parliamentary report has called for the HTA body NICE to consider the use of conditional reimbursement recommendations and more flexible cost-effectiveness thresholds in its ongoing methods review.
You may also be interested in...
UK members of parliament have called on pharmaceutical companies to be more transparent in their pricing process and to improve the way they gather and present data for health technology appraisals. They also say that industry rebates should be ring fenced to fund new medicines.
A review of UK HTA body NICE’s methods for appraising medicines will probably be constrained by budget considerations, but it should still aim to bring positive change, said Leslie Galloway of the Ethical Medicines Industry Group.